Topic Archives: Glenn Rothfeld

One would think that it would take a person of normal intelligence about half a minute to conclude that lures such as the ones below could not possibly be on the up and up.   Here’s one.  It starts out with a note from Christine O’Brien. “The Sovereign Investor Daily A brand new, ‘Alzheimer’s vaccine’ […]

Comments

  • Avatar

    Yes. The repair is based on tideglusib which is produced by a Spanish company called Noscira which is a divison of Zelti...

  • Avatar

    from: http://www.edisoninvestmentresearch.com/research/report/pharmamar/preview/ "The former Zeltia Group has rest...

  • Avatar

    Hate to seem unintelligent but my best guess on this is a company call Pharmacy Mar said to be merging with another comp...

  • Avatar

    Wasn't there a recent reverse merger of the parent company (Zeltia) into the subsidiary (PharmaMar), which is the produc...

  • Avatar

    The internet is a glorious and wonderful tool if used correctly and asked the right questions. Here are 3 questions I...

  • Avatar

    Zeltia is the Spanish Parent. But their pharma involvement is small. I believe the Zeltia subsidiary PharmaMar USA i...

  • Avatar

    I found this abstract write up on Trabectedin: Ecteinascidin 743. I also saw this reference to a new NASDAQ filing a ...

  • Avatar

    Try Zeltia a Spanish phama.- Trabectedin (also known as ecteinascidin 743. Sold by zeltia n J&J...

  • Avatar

    Probably is this medicament http://www.yondelis.com/ to the spanish group PHARMA MAR R (PHM.MC) and Janssen. In the spa...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info